American Society of Hirudotherapy

Therapeutic Potentials of Medicinal Leech in Chinese Medicine

Wu S, Zhou Y, Wang Y, Zhang Z (2024) · The American Journal of Chinese Medicine

Expert opinion / guidance: Content is historical, educational, or biographical reference material — not a clinical recommendation.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Type
narrative review of medicinal-leech use in Traditional Chinese Medicine, with focus on Whitmania pigra (non-hematophagous), Hirudo nipponia, and Hirudinaria manillensis; Central South University Xiangya School of Medicine, China
Scope
Synthesis of Chinese pharmacopeia leech species used orally and topically in TCM formulations for anti-inflammatory, cardiovascular, and antitumor indications; bioactive constituent profile

Key Findings

  • Chinese Pharmacopeia recognizes Whitmania pigra (non-hematophagous), Hirudo nipponia, and Hirudinaria manillensis as medicinal leeches
  • Bioactives stratified into coagulation-system targets (hirudin family, heparin, histamine) and protease-inhibitor groups (Decorsin, Hementin)
  • Hirudin remains the most potent salivary-gland thrombin inhibitor
  • TCM applications cited in anti-inflammatory, cardiovascular, and antitumor contexts
  • Cross-regulatory species context valuable for global hirudotherapy literature

Limitations

  • Narrative review without systematic search or quality grading
  • TCM clinical evidence reviewed is mostly from regional Chinese-language sources
  • Many cited mechanisms are preclinical or in-vitro
  • Direct translation to US K040187 clinical practice not appropriate
  • Antitumor and broad therapeutic claims insufficiently supported by RCT-level evidence

Clinical Implications

Wu 2024 serves as a regulatory and species-comparative reference for ASH's understanding of how non-Hirudo-medicinalis species (especially Whitmania pigra and Hirudinaria manillensis) are used in Chinese medicine. For US clinicians under K040187, the review does not change practice but provides important historical and pharmacognosy context. The review usefully complements ASH's existing entries on H. nipponia (Lu 2018), Whitmania pigra hirudins (Müller 2022), and the broader hirudin-family literature.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.